Subscribe
shutterstock_1537866854_sundry_photography
Sundry Photography / Shutterstock.com
25 February 2021AmericasMuireann Bolger

Nevro escalates patent dispute with Boston Scientific

Medical device maker Nevro has hit competitor Boston Scientific (BSC) with a lawsuit for allegedly infringing patents that cover a spinal cord stimulation technology.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Medtech
Nevro claims BSC destroyed evidence in patent suit
26 October 2021   Boston Scientific (BSC) and Nevro will testify before a Delaware Federal Court today following pleas from Nevro to delay the trial due to claims that BSC destroyed evidence related to a patent damages case.
Medtech
Beckman Coulter loses late-stage bid to pause infringement proceedings
17 May 2022   The US District Court for the District of Delaware has denied a motion from Beckman Coulter to stay an patent infringement lawsuit involving Sysmex Corporation until parallel proceedings at the US Court of Appeals for the Federal Circuit are concluded.
Big Pharma
Boston Scientific loses stent patent case in uni feud
2 February 2023   Delaware jury finds that the infringement was intentional | Verdict comes in a long-running dispute that touched upon state sovereignty.


Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024

More on this story

Medtech
Nevro claims BSC destroyed evidence in patent suit
26 October 2021   Boston Scientific (BSC) and Nevro will testify before a Delaware Federal Court today following pleas from Nevro to delay the trial due to claims that BSC destroyed evidence related to a patent damages case.
Medtech
Beckman Coulter loses late-stage bid to pause infringement proceedings
17 May 2022   The US District Court for the District of Delaware has denied a motion from Beckman Coulter to stay an patent infringement lawsuit involving Sysmex Corporation until parallel proceedings at the US Court of Appeals for the Federal Circuit are concluded.
Big Pharma
Boston Scientific loses stent patent case in uni feud
2 February 2023   Delaware jury finds that the infringement was intentional | Verdict comes in a long-running dispute that touched upon state sovereignty.

More on this story

Medtech
Nevro claims BSC destroyed evidence in patent suit
26 October 2021   Boston Scientific (BSC) and Nevro will testify before a Delaware Federal Court today following pleas from Nevro to delay the trial due to claims that BSC destroyed evidence related to a patent damages case.
Medtech
Beckman Coulter loses late-stage bid to pause infringement proceedings
17 May 2022   The US District Court for the District of Delaware has denied a motion from Beckman Coulter to stay an patent infringement lawsuit involving Sysmex Corporation until parallel proceedings at the US Court of Appeals for the Federal Circuit are concluded.
Big Pharma
Boston Scientific loses stent patent case in uni feud
2 February 2023   Delaware jury finds that the infringement was intentional | Verdict comes in a long-running dispute that touched upon state sovereignty.

More features

Bayer gains exclusive licence for heart drug in Japan
EPO delivers key Novo Nordisk, GSK and Inhibrx rulings
McGuireWoods expands team with ex-Novo Nordisk GC
Paul, Weiss swoops for senior duo from Weil, Gotshal
UPC bans Meril Life Sciences from selling infringing heart valve
SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic
Kathi Vidal to rejoin previous firm as partner following USPTO departure
GSK triumphs in EPO appeal, revoking Pfizer patent